Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer

Yan Cui, Esther A. Koop, Paul J. Van Diest, Rita A. Kandel, Thomas E. Rohan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Certain nuclear morphometric features measured in breast tumor tissue have been shown to predict the prognosis of breast cancer patients. However, the application of these features to predicting risk of breast cancer development has received little attention. We conducted a case-control study to evaluate nuclear morphometric features in benign breast tissue in association with subsequent breast cancer risk. The study was nested within a cohort of 4,888 women with a histopathologic diagnosis of benign breast disease (BBD) and involved 61 cases and 71 controls, amongst whom there were 53 matched case-control sets. Conditional logistic regression models were fitted to assess various measurements of nuclear size and nuclear shape factors in relation to subsequent breast cancer risk. In multivariate analysis, subsequent breast cancer risk was positively associated with a nuclear shape factor that takes the shortest nuclear axis and the longest nuclear axis into consideration simultaneously (highest quartile versus lowest 3 quartiles: odds ratio = 3.07, 95% confidence limits = 1.61, 5.84). In contrast, there was no alteration in subsequent breast cancer risk in association with nuclear size features and other shape factors. In conclusion, our study results suggest that the shape factor that takes both the shortest nuclear axis and the longest nuclear axis into consideration might be of value to predict subsequent development of breast cancer among women with BBD.

Original languageEnglish (US)
Pages (from-to)103-107
Number of pages5
JournalBreast Cancer Research and Treatment
Volume104
Issue number1
DOIs
StatePublished - Jul 2007

Fingerprint

Breast
Breast Neoplasms
Breast Diseases
Logistic Models
Case-Control Studies
Multivariate Analysis
Odds Ratio

Keywords

  • Benign breast disease
  • Breast cancer
  • Morphometry
  • Nuclear shape
  • Nuclear size

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer. / Cui, Yan; Koop, Esther A.; Van Diest, Paul J.; Kandel, Rita A.; Rohan, Thomas E.

In: Breast Cancer Research and Treatment, Vol. 104, No. 1, 07.2007, p. 103-107.

Research output: Contribution to journalArticle

Cui, Yan ; Koop, Esther A. ; Van Diest, Paul J. ; Kandel, Rita A. ; Rohan, Thomas E. / Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer. In: Breast Cancer Research and Treatment. 2007 ; Vol. 104, No. 1. pp. 103-107.
@article{25551f5f7935416b913b518fdb2c2c3f,
title = "Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer",
abstract = "Certain nuclear morphometric features measured in breast tumor tissue have been shown to predict the prognosis of breast cancer patients. However, the application of these features to predicting risk of breast cancer development has received little attention. We conducted a case-control study to evaluate nuclear morphometric features in benign breast tissue in association with subsequent breast cancer risk. The study was nested within a cohort of 4,888 women with a histopathologic diagnosis of benign breast disease (BBD) and involved 61 cases and 71 controls, amongst whom there were 53 matched case-control sets. Conditional logistic regression models were fitted to assess various measurements of nuclear size and nuclear shape factors in relation to subsequent breast cancer risk. In multivariate analysis, subsequent breast cancer risk was positively associated with a nuclear shape factor that takes the shortest nuclear axis and the longest nuclear axis into consideration simultaneously (highest quartile versus lowest 3 quartiles: odds ratio = 3.07, 95{\%} confidence limits = 1.61, 5.84). In contrast, there was no alteration in subsequent breast cancer risk in association with nuclear size features and other shape factors. In conclusion, our study results suggest that the shape factor that takes both the shortest nuclear axis and the longest nuclear axis into consideration might be of value to predict subsequent development of breast cancer among women with BBD.",
keywords = "Benign breast disease, Breast cancer, Morphometry, Nuclear shape, Nuclear size",
author = "Yan Cui and Koop, {Esther A.} and {Van Diest}, {Paul J.} and Kandel, {Rita A.} and Rohan, {Thomas E.}",
year = "2007",
month = "7",
doi = "10.1007/s10549-006-9396-4",
language = "English (US)",
volume = "104",
pages = "103--107",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer

AU - Cui, Yan

AU - Koop, Esther A.

AU - Van Diest, Paul J.

AU - Kandel, Rita A.

AU - Rohan, Thomas E.

PY - 2007/7

Y1 - 2007/7

N2 - Certain nuclear morphometric features measured in breast tumor tissue have been shown to predict the prognosis of breast cancer patients. However, the application of these features to predicting risk of breast cancer development has received little attention. We conducted a case-control study to evaluate nuclear morphometric features in benign breast tissue in association with subsequent breast cancer risk. The study was nested within a cohort of 4,888 women with a histopathologic diagnosis of benign breast disease (BBD) and involved 61 cases and 71 controls, amongst whom there were 53 matched case-control sets. Conditional logistic regression models were fitted to assess various measurements of nuclear size and nuclear shape factors in relation to subsequent breast cancer risk. In multivariate analysis, subsequent breast cancer risk was positively associated with a nuclear shape factor that takes the shortest nuclear axis and the longest nuclear axis into consideration simultaneously (highest quartile versus lowest 3 quartiles: odds ratio = 3.07, 95% confidence limits = 1.61, 5.84). In contrast, there was no alteration in subsequent breast cancer risk in association with nuclear size features and other shape factors. In conclusion, our study results suggest that the shape factor that takes both the shortest nuclear axis and the longest nuclear axis into consideration might be of value to predict subsequent development of breast cancer among women with BBD.

AB - Certain nuclear morphometric features measured in breast tumor tissue have been shown to predict the prognosis of breast cancer patients. However, the application of these features to predicting risk of breast cancer development has received little attention. We conducted a case-control study to evaluate nuclear morphometric features in benign breast tissue in association with subsequent breast cancer risk. The study was nested within a cohort of 4,888 women with a histopathologic diagnosis of benign breast disease (BBD) and involved 61 cases and 71 controls, amongst whom there were 53 matched case-control sets. Conditional logistic regression models were fitted to assess various measurements of nuclear size and nuclear shape factors in relation to subsequent breast cancer risk. In multivariate analysis, subsequent breast cancer risk was positively associated with a nuclear shape factor that takes the shortest nuclear axis and the longest nuclear axis into consideration simultaneously (highest quartile versus lowest 3 quartiles: odds ratio = 3.07, 95% confidence limits = 1.61, 5.84). In contrast, there was no alteration in subsequent breast cancer risk in association with nuclear size features and other shape factors. In conclusion, our study results suggest that the shape factor that takes both the shortest nuclear axis and the longest nuclear axis into consideration might be of value to predict subsequent development of breast cancer among women with BBD.

KW - Benign breast disease

KW - Breast cancer

KW - Morphometry

KW - Nuclear shape

KW - Nuclear size

UR - http://www.scopus.com/inward/record.url?scp=34250795715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250795715&partnerID=8YFLogxK

U2 - 10.1007/s10549-006-9396-4

DO - 10.1007/s10549-006-9396-4

M3 - Article

VL - 104

SP - 103

EP - 107

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -